IL33336A0 - 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them - Google Patents
1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing themInfo
- Publication number
- IL33336A0 IL33336A0 IL33336A IL3333669A IL33336A0 IL 33336 A0 IL33336 A0 IL 33336A0 IL 33336 A IL33336 A IL 33336A IL 3333669 A IL3333669 A IL 3333669A IL 33336 A0 IL33336 A0 IL 33336A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrazin
- imidazo
- ones
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77747868A | 1968-11-20 | 1968-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL33336A0 true IL33336A0 (en) | 1970-01-29 |
Family
ID=25110370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33336A IL33336A0 (en) | 1968-11-20 | 1969-11-10 | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3567725A (xx) |
| AT (1) | AT290528B (xx) |
| BE (1) | BE741910A (xx) |
| BR (1) | BR6914329D0 (xx) |
| DE (2) | DE1965989A1 (xx) |
| FR (1) | FR2035817B1 (xx) |
| GB (1) | GB1246006A (xx) |
| IL (1) | IL33336A0 (xx) |
| NL (1) | NL6915957A (xx) |
| ZA (1) | ZA698081B (xx) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810933D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Heterocyclic compounds |
| GB8810934D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Amides |
| US5705585A (en) * | 1993-06-30 | 1998-01-06 | Arqule, Inc. | Aminimide-containing molecules and materials as molecular recognition agents |
| US7034110B2 (en) * | 1994-01-05 | 2006-04-25 | Arqule, Inc. | Method of identifying chemical compounds having selected properties for a particular application |
| EP0743857A4 (en) * | 1994-01-05 | 1998-07-15 | Arqule Inc | PROCESS FOR THE PREPARATION OF POLYMERS HAVING SPECIFIC PROPERTIES |
| US5734082A (en) * | 1994-10-20 | 1998-03-31 | Arqule Inc. | Hydroxyethyl aminimides |
| US5712171A (en) * | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| AU5438796A (en) * | 1995-04-06 | 1996-10-23 | Arqule, Inc. | Method for rapid purification, analysis and characterization of collections of chemical compounds |
| US5962412A (en) * | 1996-06-10 | 1999-10-05 | Arqule, Inc. | Method of making polymers having specific properties |
| KR101504669B1 (ko) * | 2006-10-19 | 2015-03-20 | 시그날 파마소티칼 엘엘씨 | 헤테로아릴 화합물, 이들의 조성물 그리고 단백질 키나아제 억제제로서의 이들의 용도 |
| US8110578B2 (en) | 2008-10-27 | 2012-02-07 | Signal Pharmaceuticals, Llc | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway |
| ES2613664T3 (es) | 2009-10-26 | 2017-05-25 | Signal Pharmaceuticals, Llc | Procedimientos de síntesis y purificación de compuestos de heteroarilo |
| BR112014009755B1 (pt) | 2011-10-19 | 2022-09-13 | Signal Pharmaceuticals, Llc | Tratamento de câncer com inibidores de quinase tor |
| CA3125862A1 (en) | 2011-12-02 | 2013-06-06 | Signal Pharmaceuticals, Llc | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use |
| BR112014020786A2 (pt) | 2012-02-24 | 2020-10-27 | Signal Pharmaceuticals, Llc | método para tratamento de câncer de pulmão, método para alcançar um critério de avaliação de resposta em tumores sólidos, método para aumento da sobrevivência |
| AU2013203714B2 (en) | 2012-10-18 | 2015-12-03 | Signal Pharmaceuticals, Llc | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity |
| CN105188704B (zh) | 2013-01-16 | 2017-09-19 | 西格诺药品有限公司 | 被取代的吡咯并嘧啶化合物、其组合物和使用其的治疗方法 |
| JP6382946B2 (ja) | 2013-04-17 | 2018-08-29 | シグナル ファーマシューティカルズ，エルエルシー | ジヒドロピラジノ−ピラジンによる癌治療 |
| TW201521725A (zh) | 2013-04-17 | 2015-06-16 | Signal Pharm Llc | 使用ｔｏｒ激酶抑制劑組合療法以治療癌症之方法 |
| TWI631950B (zh) | 2013-04-17 | 2018-08-11 | 標誌製藥公司 | 藉二氫吡𠯤并吡𠯤治療癌症 |
| EP2986321A1 (en) | 2013-04-17 | 2016-02-24 | Signal Pharmaceuticals, LLC | Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer |
| PE20160041A1 (es) | 2013-04-17 | 2016-01-28 | Signal Pharm Llc | FORMULACIONES FARMACEUTICAS, PROCESO, FORMAS SOLIDAS Y METODOS DE USO RELACIONADOS CON 1-ETIL-7-(2-METIL-6-(1H-1,2,4-TRIAZOL-3-IL)PIRIDIN-3-IL)-3,4-DIHIDROPIRAZINO[2,3-b]PIRAZIN-2(1H)-ONA |
| CA2909625C (en) | 2013-04-17 | 2021-06-01 | Signal Pharmaceuticals, Llc | Combination therapy comprising a tor kinase inhibitor and a 5-substituted quinazolinone compound for treating cancer |
| CA2908957C (en) | 2013-04-17 | 2021-05-18 | Signal Pharmaceuticals, Llc | Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer |
| GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| JP6401250B2 (ja) | 2013-05-29 | 2018-10-10 | シグナル ファーマシューティカルズ，エルエルシー | ７−（６−（２−ヒドロキシプロパン−２−イル）ピリジン−３−イル）−１−（（ｔｒａｎｓ）−４−メトキシシクロヘキシル）−３，４−ジヒドロピラジノ［２，３−ｂ］ピラジン−２（１Ｈ）−オン、その固体形態の医薬組成物、及びその使用方法 |
| WO2015160880A1 (en) | 2014-04-16 | 2015-10-22 | Signal Pharmaceuticals, Llc | SOLID FORMS COMPRISING 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL) PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO(2,3-b)PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF |
| US9718824B2 (en) | 2014-04-16 | 2017-08-01 | Signal Pharmaceuticals, Llc | Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof |
| NZ714742A (en) | 2014-04-16 | 2017-04-28 | Signal Pharm Llc | Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use |
| WO2015160868A1 (en) | 2014-04-16 | 2015-10-22 | Signal Pharmaceuticals, Llc | Methods for treating cancer using tor kinase inhibitor combination therapy |
| NZ629796A (en) | 2014-07-14 | 2015-12-24 | Signal Pharm Llc | Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use |
| EA201790189A1 (ru) | 2014-07-14 | 2017-11-30 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Способы лечения злокачественного новообразования с использованием замещенных пирролопиримидиновых соединений, композиции на их основе |
| SG11201912403SA (en) | 2017-06-22 | 2020-01-30 | Celgene Corp | Treatment of hepatocellular carcinoma characterized by hepatitis b virus infection |
-
1968
- 1968-11-20 US US777478A patent/US3567725A/en not_active Expired - Lifetime
-
1969
- 1969-10-22 NL NL6915957A patent/NL6915957A/xx unknown
- 1969-11-10 IL IL33336A patent/IL33336A0/xx unknown
- 1969-11-17 DE DE19691965989 patent/DE1965989A1/de active Pending
- 1969-11-17 DE DE19691957711 patent/DE1957711A1/de active Pending
- 1969-11-17 GB GB56181/69A patent/GB1246006A/en not_active Expired
- 1969-11-19 BR BR214329/69A patent/BR6914329D0/pt unknown
- 1969-11-19 BE BE741910D patent/BE741910A/xx unknown
- 1969-11-19 ZA ZA698081*A patent/ZA698081B/xx unknown
- 1969-11-19 AT AT1082569A patent/AT290528B/de not_active IP Right Cessation
- 1969-11-20 FR FR696939941A patent/FR2035817B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2035817B1 (xx) | 1973-01-12 |
| GB1246006A (en) | 1971-09-15 |
| BR6914329D0 (pt) | 1973-02-22 |
| US3567725A (en) | 1971-03-02 |
| ZA698081B (en) | 1971-07-28 |
| AT290528B (de) | 1971-06-11 |
| DE1957711A1 (de) | 1970-06-18 |
| NL6915957A (xx) | 1970-05-22 |
| BE741910A (xx) | 1970-05-19 |
| FR2035817A1 (xx) | 1970-12-24 |
| DE1965989A1 (de) | 1971-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL33336A0 (en) | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them | |
| YU215269A (en) | Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido (2,3-b) (184)benzodiazepin-6-ones | |
| IL30463A0 (en) | 1h-imidazo(4,5-beta)pyrazine-2-ones and process for their preparation | |
| YU133669A (en) | Process for preparing 2-bromo-alfa-ergocryptine | |
| YU169669A (en) | Process for preparing delta-aminocyclohexadienyl alkylene-penicillin | |
| IL31950A (en) | Alkyl-6,7-aziridino-7-deoxy-alpha-thiolincosaminides and process for preparing them | |
| YU34529B (en) | Process for preparing 1,3,4-thiadiazolyl (5)-carbamides | |
| YU35584B (en) | Process for preparing 1,1,1-trichloro etane derivatives | |
| IL32243A (en) | Process for preparing quinoxaline-di-n-oxides | |
| YU33976B (en) | Process for preparing 4,20,22-bufatrienolide-rhamnoside-ethers | |
| IL27455A (en) | 3-methyl-1h-pyrazolo(3,4-b)pyridines and process for their preparation | |
| YU298769A (en) | Process for preparing omega-cyanoalkylcarbamyl-benzimidazoles | |
| YU123469A (en) | Process for preparing novel 1,3,4-thiadiazolyl-carbamates | |
| IL27443A (en) | Isoxazolo(5,4-b)pyridines and process for preparing same | |
| YU34354B (en) | Process for preparing 4-aryl-1-(4,4-diaryl-butyl)-4hydroxypiperidines | |
| YU188969A (en) | Process for preparing corticoid-21-mono-phospahtes | |
| YU40073A (en) | Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepine-6-ones | |
| YU34417B (en) | Process for preparing 2,4-diamino-6-alkylthio-s-triazines | |
| YU289578A (en) | Process for obtaining imidazo (4,5-b) pyridines | |
| YU1469A (en) | Process for preparing delta-carboxybenzyl-penicillin | |
| YU131369A (en) | Process for preparing 1-benzyl-3-3dimethylaminopropoxy-1h--indazole | |
| IL22912A (en) | Pyrido(3,4-b)indoles and process for their preparation | |
| YU155069A (en) | Process for preparing p-hydroxybutyrophenones | |
| CA891505A (en) | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing | |
| YU34081B (en) | Process for preparing and isolating 1,2-dimethyl-5-nitroimidazoles |